Health Net, Inc. (HNT)
Annual Shareholder Meeting Call
May 22, 2012 13:00 ET
Roger Greaves – Chairman
Angelee Bouchard – Senior Vice President, General Counsel, and Corporate Secretary
Jay Gellert – President and Chief Executive Officer
Roger Greaves – Chairman
Good morning, ladies and gentlemen. It’s my pleasure to welcome you to the 2012 Annual Meeting of the Stockholders of Health Net Incorporated. I am Roger F. Greaves, Chairman of the Board of Directors of Health Net, I’ll act as Chairman of this meeting and Angelee Bouchard, Senior Vice President, General Counsel and Secretary will act as Secretary. I’ve been advised that a quorum is present and it’s now 10 O’clock Pacific Time and in accordance with the notice of the meeting, Health Net’s 2012 Annual Meeting of Stockholders is now called to order. If you are attending this meeting in person, please make sure you’ve signed in.
Before we begin with the formalities of the meeting, I’d like to introduce Jay Gellert, our President and CEO. Jay is also a Director of the company. Jay? I’d also like to introduce the other members of the company’s Board of Directors who are here with us today. Please stand as you are introduced or wave your hand, Mary Anne Citrino, Theodore Craver, Vicki Escarra, Gale Fitzgerald, Patrick Foley, Bruce Willison, and Frederick Yeager.
Biographies and other information about each of our Directors including myself are included in the proxy statement that was mailed to our stockholders. Representatives from the accounting firm of Deloitte & Touche are also present at our meeting today. Deloitte & Touche has been selected as our independent register public accounting firm for 2012 and their selection is being submitted to our stockholders for ratification of this meeting.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts